Clever Culture Systems Limited has released a press release.
Non-Renounceable Rights Issue
Filed with ASX ·
6ix hasn’t read this filing yet.
Clever Culture Systems Limited on 6ix
Earlier from Clever Culture Systems
- $1.5M Funding Awarded for New APAS Instrument
- Direct Sale of APAS Independence in United States
- Purchase Order for Multiple APAS Instruments
- LBT Investor Call to discuss CCS Acquisition
- LBT Completes CCS Acquisition
Later from Clever Culture Systems
- Rights Issue Prospectus
- Non-renounceable Rights Issue Results
- CCS Appoint Thermo Fisher as Exclusive European Distributor
- LBT Strengthens APAS Pharma Development
- AstraZeneca Partners LBT for APAS Pharma Development
Follow Clever Culture Systems into a list and get an email when it puts out news.
Follow Clever Culture Systems